SRGAP2a was downregulated in DKD patients and db/db mice exhibiting disrupted podocyte cytoskeletons, and SRGAP2a knockdown in podocytes rearranged the cytoskeleton by inactivating RhoA/Cdc42 [107]. This evidence concerns the gene RHOA and diabetic kidney disease.